Glycosides: rutoside (rutin) and its derivatives

In 2024, glycosides: rutoside (rutin) and its derivatives trade exhibited slight decline, with global flows reaching $154,834,632 and a three-year compound annual growth rate of -0.5% (five-year: +6.9%). The all-time peak of $177,310,478 was recorded in 2022; the current level is 13% below that high-water mark.

Over the 30-year observation window (1995–2024), 52% of years recorded positive growth, indicating a mildly upward trajectory with periodic contractions. Trend momentum is steady (-0.7% acceleration).

The World Trade Flows Characterization classifies glycosides: rutoside (rutin) and its derivatives as "One-way trade" in the unclassified price segment, providing additional context for market positioning and competitive dynamics.

The supply side is moderately concentrated (Herfindahl-Hirschman Index 0.236). The three largest exporters — China ($57.1M), Spain ($39.8M), and Hungary ($28.5M) — collectively dominate supply flows. The leading exporter has grown at +1.3% over the last three years.

On the demand side, importer concentration is diversified (HHI 0.097). The three largest import markets are France ($39.3M), Germany ($14.0M), and Japan ($10.7M). The largest importing market sources from 15 different supplying countries.

The dominant trade corridor is Hungary → France at $28.4M, representing 72.4% of the importer's total demand.

The volatility score for glycosides: rutoside (rutin) and its derivatives is 6 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, contracting demand signals caution before committing resources. A moderately concentrated market rewards differentiated positioning and strategic partner selection.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.